Suchergebnisse - "Higashi, Taishi"

PubPharm (226)

1

Sustained Release Formulation of Hydroxypropyl-β-cyclodextrin Eye Drops Using Xanthan Gum

enthalten in: Chemical & pharmaceutical bulletin | 2024

von Higashi, T. | Goto, T. | Onodera, R. | +3

2

Cyclodextrin-based tailored polyrotaxanes for highly efficient delivery of the genome-editing molecule

enthalten in: Carbohydrate polymers | 2024

von Taharabaru, T. | Kihara, T. | Obata, A. | +5

3

CARRIER FOR FUNCTIONAL NUCLEIC ACID AND PROTEIN INTRODUCTION

enthalten in: Europäisches Patentamt | 2023

von HIGASHI TAISHI | MOTOYAMA KEIICHI | ONODERA RISAKO | +2

4

CARRIER FOR FUNCTIONAL NUCLEIC ACID AND PROTEIN INTRODUCTION

enthalten in: Europäisches Patentamt | 2023

von HIGASHI TAISHI | MOTOYAMA KEIICHI | ONODERA RISAKO | +2

5

Folate-Appended Hydroxypropyl-β-Cyclodextrin Induces Autophagic Cell Death in Acute Myeloid Leukemia Cells

enthalten in: International journal of molecular sciences | 2023

von Kubota, Y. | Hoshiko, T. | Higashi, T. | +3

6

BORONIC ACID-CONTAINING MODIFIED POLYROTAXANE

enthalten in: Europäisches Patentamt | 2023

von HIGASHI TAISHI | MOTOYAMA KEIICHI | ONODERA RISAKO | +1

7

BORONIC ACID-CONTAINING MODIFIED POLYROTAXANE

enthalten in: Europäisches Patentamt | 2023

von HIGASHI TAISHI | MOTOYAMA KEIICHI | ONODERA RISAKO | +1

8

Tannic acid-based sustained-release system for protein drugs

enthalten in: International journal of pharmaceutics | 2023

von Utatsu, K. | Motoyama, K. | Nakamura, T. | +2

9

Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann-Pick disease type C treatment

enthalten in: Clinical and translational medicine | 2023

von Yamada, Y. | Fukaura-Nishizawa, M. | Nishiyama, A. | +23

10

Versatile delivery platform for nucleic acids, negatively charged protein drugs, and genome-editing ribonucleoproteins using a multi-step transformable polyrotaxane

enthalten in: Materials today. Bio | 2023

von Taharabaru, T. | Kihara, T. | Onodera, R. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]